Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Commentaries

The Use of Mendelian Randomization to Determine the Role of Metabolic Traits on Urinary Albumin-to-Creatinine Ratio

  1. Sharon M. Lutz1,2 and
  2. John E. Hokanson3⇑
  1. 1PRecisiOn Medicine Translational Research (PROMoTeR) Center, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA
  2. 2Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA
  3. 3Department of Epidemiology, University of Colorado, Anschutz Medical Campus, Aurora, CO
  1. Corresponding author: John E. Hokanson, john.hokanson{at}cuanschutz.edu
Diabetes 2020 May; 69(5): 862-863. https://doi.org/10.2337/dbi19-0034
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Urinary albumin-to-creatinine ratio (ACR) has both genetic and environmental influences. Previous studies have identified a number of genetic loci associated with ACR (1–3). Metabolic traits such as obesity and dyslipidemia also exhibit both genetic and environmental influences, and these measures have been associated with ACR (4). Previous studies indicate pleiotropic effects of metabolic genetic variants on ACR; however, it is not clear whether these metabolic traits have a causal relationship with ACR (5). In this issue of Diabetes, Casanova et al. (6) use Mendelian randomization (MR) to examine a putative causal relationship between metabolic traits and ACR.

An illustration of the potential relationship between metabolic traits and ACR is shown in Fig. 1. The association between single nucleotide polymorphisms (SNPs) identified through genome-wide association studies and metabolic traits should be established and strong; this relationship is noted by the arrow from the instrument variables (i.e., SNPs) to the metabolic trait of interest. Epidemiologic literature can be used to support the association of each metabolic trait with ACR; however, these relationships may be confounded. MR can be used to establish the relationship between the metabolic trait and ACR (this relationship is noted by the arrow from the metabolic trait to ACR in Fig. 1) by assessing the instrument variables. However, most MR methods assume that there is no direct effect of the SNPs on ACR and that there are no alternate pathways from the SNPs to ACR other than through the specific metabolic trait of interest (Fig. 1) (7).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Causal diagram of the potential relationship among instrument variables (i.e., SNPs), the metabolic trait of interest, and ACR. MR tests the association between the exposure (i.e., metabolic trait) and the outcome (i.e., ACR) using the instrument variables (SNPs derived from a genome-wide association study [GWAS] of the metabolic trait). Depicted are potential alternate pathways and direct effects of the SNPs on ACR. The metabolic trait may also be correlated with alternate pathways.

Three of the most common MR approaches are the inverse-variance weighted (IVW) method, MR-Egger, and the weighted median method (7). These three MR methods make several key assumptions. The IVW method assumes that all SNPs are valid instrumental variables for the trait and the only path from the SNPs to the outcome is through the exposure (i.e., no pleiotropy) (8). The MR-Egger method is more robust to potential violations of the standard instrumental variable assumptions, and this method is less prone to confounding from possibly pleiotropic SNPs, which could have stronger effects on outcomes compared with the effect on the exposure (9). The weighted median method improves precision and is also more robust to potential violations of the standard instrumental variable assumptions (10). While MR offers a simple way to distinguish causation from correlation, a recent article in Nature has argued that scientists may be overusing or misusing MR methods (7).

Casanova et al. (6) used these three MR approaches to consider the role of 11 metabolic risk factors on ACR. The 11 metabolic risk factors were diastolic blood pressure, systolic blood pressure, HDL cholesterol, LDL cholesterol, triglycerides, BMI, waist-to-hip ratio (adjusted by BMI), fasting glucose, fasting insulin, type 2 diabetes liability, and favorable adiposity, which represents higher adiposity but lower metabolic disease risk using genetic variants previously identified (11). Using IVW as the primary method, all of these traits except for four (HDL cholesterol, BMI, fasting glucose, and fasting insulin) had a P value <0.05.

It is a strength of the study by Casanova et al. (6) that it implemented all three popular MR approaches including the MR-Egger and weighted median methods that, as mentioned previously, are more robust to potential violations of the standard instrumental variable assumptions and potentially less prone to confounding due to pleiotropy. Pleiotropy is not uncommon when examined across the genome and is a concern in the study. For example, one variant, rs2276936 [FAM13A], an instrument variable for favorable adiposity, and a second variant, rs3822072 [FAM13A], an instrument variable for HDL cholesterol, are in linkage disequilibrium (r2 = 0.94). Given that the MR-Egger approach is less prone to confounding due to pleiotropy than the IVW approach, the MR-Egger approach would be a more valid primary method than the IVW approach for examining the role of these 11 metabolic traits on ACR when pleiotropy is likely to exist. Using the MR-Egger method, five of the metabolic traits (triglycerides, waist-to-hip ratio, BMI, fasting insulin, and type 2 diabetes liability) are significantly associated with ACR (P value <0.05), although these results would be further reduced in number if a Bonferroni correction was used to account for the multiple testing correction of the 11 metabolic traits.

Casanova et al. (6) observed a complex relationship between multiple metabolic pathways and ACR. However, given concerns over the assumptions regarding pleiotropy, the primary method used should best meet the assumptions of the given research question in that particular scenario. Their article also demonstrates the importance of directly assessing the model in Fig. 1. Future directions could examine other pathways in Fig. 1. Mediation analysis, for example, can estimate the indirect effect of a SNP in FAM13A on ACR through favorable adiposity or HDL cholesterol as well as the direct effect of that SNP on ACR. Mediation analysis may contribute to our understanding of the relative importance of these pathways on ACR and microvascular disease. Understanding the biological pathways that lead to clinically relevant outcomes is crucial in designing successful interventions. Mediation analysis can specifically test these biological pathways recognizing pleiotropic effects on these complex metabolic traits and ACR.

Article Information

Funding. Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health grant K01HL125858 (S.M.L.).

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Footnotes

  • See accompanying article, p. 1072.

  • © 2020 by the American Diabetes Association
https://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Böger CA,
    2. Chen MH,
    3. Tin A, et al.; CKDGen Consortium
    . CUBN is a gene locus for albuminuria. J Am Soc Nephrol 2011;22:555–570
    OpenUrlAbstract/FREE Full Text
    1. Haas ME,
    2. Aragam KG,
    3. Emdin CA, et al.; International Consortium for Blood Pressure
    . Genetic association of albuminuria with cardiometabolic disease and blood pressure. Am J Hum Genet 2018;103:461–473
    OpenUrlPubMed
  2. ↵
    1. Zanetti D,
    2. Rao A,
    3. Gustafsson S,
    4. Assimes TL,
    5. Montgomery SB,
    6. Ingelsson E
    . Identification of 22 novel loci associated with urinary biomarkers of albumin, sodium, and potassium excretion. Kidney Int 2019;95:1197–1208
    OpenUrlPubMed
  3. ↵
    1. Thomas G,
    2. Sehgal AR,
    3. Kashyap SR,
    4. Srinivas TR,
    5. Kirwan JP,
    6. Navaneethan SD
    . Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2011;6:2364–2373
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Casanova F,
    2. Tyrrell J,
    3. Beaumont RN, et al
    . A genome-wide association study implicates multiple mechanisms influencing raised urinary albumin-creatinine ratio. Hum Mol Genet 2019;28:4197–4207
    OpenUrl
  5. ↵
    1. Casanova F,
    2. Wood AR,
    3. Yaghootkar H, et al
    . A Mendelian randomization study provides evidence that adiposity and dyslipidemia lead to lower urinary albumin-to-creatinine ratio, a marker of microvascular function. Diabetes 2020;69:1072–1082
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Adam D
    . The gene-based hack that is revolutionizing epidemiology. Nature 2019;576:196–199
    OpenUrl
  7. ↵
    1. Burgess S,
    2. Butterworth A,
    3. Thompson SG
    . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013;37:658–665
    OpenUrlCrossRefPubMed
  8. ↵
    1. Bowden J,
    2. Davey Smith G,
    3. Burgess S
    . Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015;44:512–525
    OpenUrlCrossRefPubMed
  9. ↵
    1. Bowden J,
    2. Davey Smith G,
    3. Haycock PC,
    4. Burgess S; MedianRef
    . Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016;40:304–314
    OpenUrlCrossRefPubMed
  10. ↵
    1. Ji Y,
    2. Yiorkas AM,
    3. Frau F, et al
    . Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 2019;68:207–219
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Diabetes: 69 (5)

In this Issue

May 2020, 69(5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Use of Mendelian Randomization to Determine the Role of Metabolic Traits on Urinary Albumin-to-Creatinine Ratio
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Use of Mendelian Randomization to Determine the Role of Metabolic Traits on Urinary Albumin-to-Creatinine Ratio
Sharon M. Lutz, John E. Hokanson
Diabetes May 2020, 69 (5) 862-863; DOI: 10.2337/dbi19-0034

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

The Use of Mendelian Randomization to Determine the Role of Metabolic Traits on Urinary Albumin-to-Creatinine Ratio
Sharon M. Lutz, John E. Hokanson
Diabetes May 2020, 69 (5) 862-863; DOI: 10.2337/dbi19-0034
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Adipose Tissue Malfunction Drives Metabolic Dysfunction in Alström Syndrome
  • Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments
  • Going in Early: Hypoxia as a Target for Kidney Disease Prevention in Diabetes?
Show more Commentaries

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.